Under construction – not a live service
Sign in

Omega-3 fatty acids (fish oil) & Fatty liver disease (MASLD/MASH)

Checked 11 Nov 2026 · Fatty liver disease (MASLD/MASH)

AI-generated image

Written from the studies on PubMed, searched on 11 Nov 2026. Every number below comes from a study listed under Sources.

What people read

Posts online say that Omega-3 fatty acids (fish oil) helps with Fatty liver disease (MASLD/MASH).

What has been studied

  • 36In people33 randomised trials
  • 59In animals
  • 1Only in the lab

What the studies found

Omega-3 fatty acids (fish oil) has been tested in randomised trials in people with Fatty liver disease (MASLD/MASH).

We found 164 published papers on Omega-3 fatty acids (fish oil) and Fatty liver disease (MASLD/MASH). They were published between 2004 and 2026.

36 of them are studies in people (33 randomised trials), 40 are reviews, 59 are studies in animals and 1 are studies only in the lab.

The most important ones are listed under Sources.

What this means for you: A study in people is not proof that it helps you. Do not stop or change your medicines because of it. Ask your doctor before you start taking it.

Sources

  1. Effectiveness of nutrition education program and omega-3 supplementation on body weight, liver enzyme, lipid profile among non-alcoholic fatty liver disease patients.2026 · BMC Nutr · Randomised trial
  2. The effect of vitamin E and docosahexaenoic acid ethyl ester on Metabolic Dysfunction-Associated steatotic Liver Disease (MASLD)-A randomised, double-blind, placebo-controlled, parallel-group clinical trial (PUVENAFLD).2024 · Aliment Pharmacol Ther · Randomised trial
  3. Effects of dietary supplementation of fish oil plus vitamin D3 on gut microbiota and fecal metabolites, and their correlation with nonalcoholic fatty liver disease risk factors: a randomized controlled trial.2024 · Food Funct · Randomised trial
  4. Effect of fish oil supplementation on the concentration of miRNA-122, FGF-21 and liver fibrosis in patients with NAFLD: Study protocol for a randomized, double-blind and placebo-controlled clinical trial.2023 · Clin Nutr ESPEN · Randomised trial
  5. Elevated serum phosphatidylcholine (16:1/22:6) levels promoted by fish oil and vitamin D3 are highly correlated with biomarkers of non-alcoholic fatty liver disease in Chinese subjects.2022 · Food Funct · Randomised trial
  6. Concentrated fish oil ameliorates non-alcoholic fatty liver disease by regulating fibroblast growth factor 21-adiponectin axis.2022 · Nutrition · Randomised trial
  7. Efficacy of omega-3-rich Camelina sativa on the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, controlled trial.2022 · Eur J Gastroenterol Hepatol · Randomised trial
  8. Effect of Omega-3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLD.2022 · Hepatol Commun · Randomised trial
  9. The effects of fish oil plus vitamin D3 intervention on non-alcoholic fatty liver disease: a randomized controlled trial.2022 · Eur J Nutr · Study in people
  10. Omega-3 mechanism of action in inflammation and endoplasmic reticulum stress in mononuclear cells from overweight non-alcoholic fatty liver disease participants: study protocol for the "Brazilian Omega Study" (BROS)-a randomized controlled trial.2021 · Trials · Study in people
  11. The Impact of Omega-3 Fatty Acids on Triglyceride Levels in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-Analysis of Randomized Controlled Trials with Subgroup Analysis by Diabetes Status.2026 · Diabetes Metab Syndr Obes · Review
  12. Omega-3 polyunsaturated fatty acids and nonalcoholic fatty liver disease in adults: A meta-analysis of randomized controlled trials.2025 · Clin Nutr · Review
  13. Efficacy of fish oil supplementation on metabolic dysfunction-associated steatotic liver disease: a meta-analysis.2025 · Front Nutr · Review
  14. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.2024 · Cureus · Review
  15. Influence of Lipid Class Used for Omega-3 Fatty Acid Supplementation on Liver Fat Accumulation in MASLD.2024 · Physiol Res · Review
  16. A systematic review and meta-analysis of randomized controlled trials to evaluate plant-based omega-3 polyunsaturated fatty acids in nonalcoholic fatty liver disease patient biomarkers and parameters.2024 · Nutr Rev · Review
  17. Omega-3 fatty acids improve lipid metabolism by regulating miR-34a.2026 · Sci Rep · In animals
  18. NRF1 is upregulated by docosahexaenoic acid to ameliorate MASH through the inhibition of ER stress.2026 · Cell Death Dis · In animals
  19. Erucic acid, eicosapentaenoic acid, and docosahexaenoic acid consumption affect hepatic steatosis in mice fed a western diet.2026 · J Nutr Biochem · In animals
  20. Effects of Dietary Adjustment and Fish Oil on Lipid Metabolism, Inflammation, and Serum LPS in Non-Alcoholic Fatty Liver Disease.2025 · Bull Exp Biol Med · In animals
  21. Dietary Omega-3 Fatty Acids from Fish and Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease in a Mediterranean Population: Findings from the NUTRIHEP Cohort.2025 · Nutrients · In animals
  22. Fishing for Solutions: How Pre-Conceptional Fish Oil Supplementation in Obese Fathers Reduces Risk of Non-Alcoholic Fatty Liver Disease in Offspring Mice.2025 · Mol Nutr Food Res · In animals
  23. Fish oil and chicoric acid combination protects better against palmitate-induced lipid accumulation via regulating AMPK-mediated SREBP-1/FAS and PPARα/UCP2 pathways.2023 · Arch Physiol Biochem · In the lab
  24. Long-chain omega-3-enriched erythrocyte fatty acid pattern is associated with lower odds of obesity and metabolic dysfunction-associated steatotic liver disease.2026 · Nutr J · Other paper
  25. Association of fish oil supplementation with risk of incident severe non-alcoholic fatty liver disease: a prospective study of 488 888 individuals.2026 · Food Funct · Other paper
  26. Moderate dietary intake of omega-3 polyunsaturated fatty acids is associated with reduced all-cause mortality in metabolic dysfunction-associated steatotic liver disease.2026 · Nutr Res · Other paper
  27. Selenium Ameliorated Oxidized Fish Oil-Induced Lipotoxicity via the Inhibition of Mitochondrial Oxidative Stress, Remodeling of Usp4-Mediated Deubiquitination, and Stabilization of Pparα.2024 · Antioxid Redox Signal · Other paper

Search PubMed yourself

More checked claims

Under construction, not live – Omega-3 fatty acids (fish oil) & Fatty liver disease (MASLD/MASH) – Frontlight Research